Kyle Mak
Senior Analyst, Investment Banking
Kyle Mak is an analyst with the investment banking team at Back Bay Life Science Advisors. He joined the firm in 2021 supporting strategic deal execution for global biopharma, medtech, and diagnostic clients across a range of therapeutic areas.
Prior to joining Back Bay, Mr. Mak held roles in Business Development, Commercial and R&D Finance at Takeda. He earned a B.S in Finance from the Carroll School of Management and a B.A in Biology from Boston College.
Recent industry highlights:
Healthcare Markets Year in Review 2023 and 2024 Outlook
US and EU Healthcare Markets Update, Weekly